echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > [quick news] good news on December 12, 2019! China's first bevacizumab bioequivalent drug (amdal) has been approved for marketing, from Qilu pharmaceutical!

    [quick news] good news on December 12, 2019! China's first bevacizumab bioequivalent drug (amdal) has been approved for marketing, from Qilu pharmaceutical!

    • Last Update: 2019-12-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Good news! China's first bevacizumab bioequivalent drug (amdal) has been approved for marketing, from Qilu pharmaceutical! Recently, the National Drug Administration (nmpa) approved the registration application of bevacizumab injection (trade name: andar) developed by Qilu Pharmaceutical Co., Ltd The drug is the first bevacizumab approved in China, which is mainly used for the treatment of advanced, metastatic or recurrent non-small cell lung cancer and metastatic colorectal cancer According to the report of foreign biotechnology website gen, in 2018, the global sales of lovastazumab reached nearly 7 billion US dollars (CHF 6.849 billion) In the U.S market, mvasi (bevacizumab), a bioequivalent drug developed by Amgen and Elgin, was launched in July this year, becoming the first bevacizumab bioequivalent drug to enter the U.S market Http:// cell stem cell: a new mechanism of bone healing Recently, a study published in the journal Cell Stem Cell by researchers from Baylor Medical College revealed a new molecular mechanism, which may contribute to the maintenance and repair of adult bones, and provide the possibility for the development of treatment strategies to improve bone healing These findings suggest potential therapeutic value For example, in people with diabetes or osteoporosis, bone healing is relatively slow and other complications may occur due to limited activity Therefore, accelerated bone healing can reduce hospital stay and improve prognosis Http://news.bioon.com/article/6747778.html is the red bird's nest made by swift? In fact, the results of environmental oxidation fermentation show that in 2018, China's bird's nest consumption was over 1000 tons, but only over 100 tons were imported through the regular channels of customs "The red swallow is the result of the oxidation and fermentation of the bird's nest in the sealed hole due to the high temperature and humidity." Sun Li, an associate researcher at the Chinese Academy of inspection and quarantine, said the nutritional content of the bird's nest is not higher than that of a regular bird's nest "Blood swallow once was fried to ten thousand yuan every two, but there is no so-called blood swallow." Xu Jing, general manager of Jingdong health nourishing and health care business department, said that the nitrite content of artificially smoked red petrels exceeded 350 times Although the sales of bird's nest is hot at present, some experts say that the nutritional value of bird's nest needs more experimental data certification Http://digitalpaper.stdaily.com/http_ / 11 / content_ HTM? Div = - 1 US media: new biochemical protective clothing simulates shark skin According to a recent report on the website of mass machinery, the existing biochemical combat clothing is huge and bulky DARPA wants the new suit to have two functions One is that this kind of clothing can prevent the direct contact between the wearer and small harmful substances, forming a kind of physical barrier The second is that the protective clothing can eliminate the toxicity of harmful substances penetrating the barrier to the skin, eyes, mouth and nose Such protective clothing shall be capable of resolving at least two chemical or biological threats at the same time The enterprise bidding proposal is required to be submitted in early 2020, and then DARPA will work with the winning bidder to develop a technology demonstration service that can be worn by 2025 Http:// 1 drop blood test for 13 kinds of cancer? The fluctuation of test data may be greater than you think Recently, Toshiba announced that it has developed a new technology, which can detect 13 kinds of cancer from a drop of blood In 2020, the empirical test will be started The company also cooperates with Tokyo Medical University, National Cancer Research Center and other institutions to carry out production university research cooperation, hoping to put into production within a few years Toshiba claims that the technology uses microRNA Similar to the fingerprint database needed for investigation, it is also necessary to establish a specific microRNA database for different cancers Zhu Yunfeng said that compared with the microRNA map research of different tumors, ctDNA detection requires fewer steps Because in practical application, the more links means the greater the accumulated deviation, so the analysis based on ctDNA will be more feasible in application and more convenient for clinical promotion http://digitalpaper.stdaily.com/http_
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.